Posted in | News | Remote Monitoring

Numerex-Powered HeartAssistRemote Monitoring System Receives 2014 M2M Telehealth Award

Numerex, a leading provider of on-demand and interactive machine-to-machine (M2M) solutions enabling the Internet of Things (IoT), announced today that the HeartAssistRemote™ Monitoring System powered by Numerex recently received a 2014 M2M Telehealth Award from M2M Evolution Magazine, the leading publication covering the machine-to-machine industry.

Numerex enables the HeartAssistRemote™ device by providing cellular connectivity, gateway and application services, as well as on-going support. From the beginning, Numerex partnered with ReliantHeart to design and implement the services that power the VadLink® Network. The solution was enabled by Numerex FAST®, a cloud-based, highly scalable, horizontal service delivery platform which is complemented by an intelligent, web-based management portal. The NumerexFAST platform gives customers like ReliantHeart, the ability to offer relevant solutions to their customers; and in this case, allows clinicians to monitor patients supported by the HeartAssist product.

ReliantHeart's HeartAssistRemote™, enabled by the Numerex Network, continually receives data from heart patients and transmits the data in bursts to a controlled and secure data center. This data can be viewed remotely by health professionals and may avoid unnecessary trips to the hospital. Overall, the HeartAssistRemote™ Monitoring allows clinicians to respond proactively in the event that there is an issue with the patient's treatment regimen.

"We are honored that this ground-breaking M2M healthcare device has been recognized by the industry. Numerex has a long history of developing innovative solutions utilizing the NumerexFAST platform. Our end-to-end capabilities and services allowed the ReliantHeart solution to become a reality. For patients, remote monitoring utilizing this device permits relevant heart data to be reported around the clock to caregivers that are miles away," said Jeff Smith, Chief Innovation and Technology Officer for Numerex.

"The partnership with Numerex has been spectacular. They provided the expertise we needed along with their Numerex DNA® solution to move our idea quickly and reliably to market," said Rodger Ford, CEO of ReliantHeart.

"The solutions selected for the M2M Telehealth Award reflect the advancement of innovation driving the machine-to-machine telehealth market. It is my honor to congratulate Numerex for their innovative work and superior contribution to the rapidly evolving M2M industry," said Carl Ford, CEO of Crossfire Media, a co-publisher of M2M Evolution Magazine.

"It is my pleasure to recognize HeartAssistRemote™, an innovative solution that earned Numerex the 2014 M2M Telehealth Award," said Rich Tehnrani, CEO, TMC. "I look forward to seeing more innovative solutions from Numerex in the future."

The winners of the 2014 M2M Telehealth Award will be published in M2M EVOLUTION MAGAZINE and on For more information, please visit

The HeartAssist5® is a device limited by Federal law to investigational use in the United States. This release is not an advertisement of the HeartAssist5 device but an announcement of an award based on Numerex's contribution to its wireless connectivity.

About ReliantHeart

ReliantHeart is a pioneer in the accelerating field of Mechanical Circulatory Support. Using advanced technologies, ReliantHeart manufactures the powerful, miniature, implantable electric HeartAssist5® Left Ventricular Assist Device that increases the cardiac output of a failing heart. The Next Generation HeartAssist5® system is currently sold commercially outside of the United States and the wireless system is not yet approved for human use.

About Crossfire Media

Crossfire Media is an integrated marketing company with a core focus on future trends in technology. We service communities of interest with conferences, tradeshows, webinars and newsletters. Crossfire Media has a partnership with Technology Marketing Corporation (TMC) to produce events and websites related to disruptive technologies. Crossfire Media is a division of Crossfire Consulting, a full service Information Technology company based in New York.

About TMC

TMC is a global, integrated media company that helps clients build communities in print, in person and online. TMC publishes multiple magazines including CUSTOMER, INTERNET TELEPHONY, M2M Evolution and Cloud Computing. TMCnet is read by more than 1.5 million unique visitors each month, and is the leading source of news and articles for the communications and technology industries. TMC is also the producer of ITEXPO, the world's leading B2B communications event, as well as industry events: M2M Evolution; Cloud4SMB Expo; DevCon5; HTML5 Summit; Super Wi-Fi Summit, CVx; AstriCon; StartupCamp, and more. Visit TMC Events for a complete listing and further information. For more information about TMC, visit

About Numerex

Numerex Corp. (Nasdaq:NMRX) is a leading provider of interactive and on-demand machine-to-machine (M2M) enterprise solutions enabling the Internet of Things (IoT). The Company provides its technology and services through its integrated M2M horizontal platforms which are generally sold on a subscription basis. The Company offers Numerex DNA® that may include hardware and smart Devices, cellular and satellite Network services, and software Applications that are delivered through Numerex FAST® (Foundation Application Software Technology). The Company also provides business services to enable the development of efficient, reliable, and secure solutions while accelerating deployment. Numerex is ISO 27001 information security-certified, highlighting the Company's focus on M2M data security, service reliability and around-the-clock support of its customers' M2M solutions. For additional information, please visit


Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.